CRISPR gets its first FDA authorization with a COVID-19 test
While COVID-19 tests are universally welcomed, CRISPR’s other uses have met resistance.
The U.S. Food and Drug Administration has granted Emergency Use Authorization to a COVID-19 test that uses the controversial gene-editing technology CRISPR.